Heteroaryl substituted piperidine derivatives as L-CPT1 inhibitors

Details for Australian Patent Application No. 2006319247 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Ackermann, Jean; Mattei, Patrizio; Schulz-Gasch, Tanja; Bleicher, Konrad; Chomienne, Odile; Ceccarelli Grenz, Simona M.

Agent Spruson & Ferguson

Pub. Number AU-B-2006319247

PCT Pub. Number WO2007/063012

Priority 05111560.8 01.12.05 EP

Filing date 22 November 2006

Wipo publication date 7 June 2007

Acceptance publication date 11 March 2010

International Classifications

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/08 (2006.01) Drugs for disorders of the metabolism

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/063012 Priority application(s): WO2007/063012

17 July 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name F. Hoffmann-La Roche AG, Application No. 2006319247, under INID (54), correct the title to read Heteroaryl substituted piperidine derivatives as L-CPT1 inhibitors

11 March 2010 Application Accepted

  Published as AU-B-2006319247

8 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006319248-2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between P53 and MDM2 proteins for use as anticancer agents

2006319245-Novel vinylogous acids derivatives